Atlas Trials

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

Clinical trial NCT03267498 · COMPLETED

Trial details

NCT number
NCT03267498
Sponsor
Sue Yom
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2018-02-14
Primary completion
2024-10-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.